ICL Q3 Deck: ELEVATE Targets >$350M EBITDA Benefit by FY2028, 2027 Reorg
ICL is trading near its 52-week low of $4.35 (7.4% above the low) on elevated volume (2.3× avg).
Summary
ICL's Q3 2026 investor deck repeats the morning's results but adds new detail: ELEVATE cost savings targeted at more than $150M of adjusted EBITDA in FY2027 and more than $350M by FY2028, plus a 2027 reorganization into four business units.
Key Events · Earnings and Guidance · ICL
-
Q3 Results Detail Reinforced
Sales of $1.91B (+3%) and adjusted EBITDA of $402M (+1%) versus $1.85B and $398M a year earlier; gross margin 32.9%, the best since Q4 2024.
-
ELEVATE Savings Targets Quantified
Management guides to more than $150M of adjusted EBITDA benefit in FY2027 and more than $350M in FY2028, split roughly 50-60% productivity, 30-40% external spend and 10-20% SG&A.
-
2027 Reorganization Into Four Units
The company will move to Nutrition Solutions, Industrial Products, Growing Solutions and Essential Minerals in 2027, shifting phosphate commodities and supplements/pharma between units.
-
Segment Split: Bromine Up, Potash Down
Industrial Products EBITDA rose to $100M from $67M on higher bromine prices; Potash EBITDA fell to $157M from $169M despite a CIF price of $370/ton versus $353, hit by a stronger shekel and higher energy and logistics costs.
Analysis · ICL · Industrial Applications And Services
The headline numbers were already out this morning, but the deck carries the forward-looking pieces investors will trade on: ELEVATE is guided to add more than $150M to adjusted EBITDA in FY2027 and more than $350M by FY2028, and the company will reorganize into four units in 2027. It also shows where the quarter's profit came from. Industrial Products EBITDA jumped to $100M from $67M on higher bromine prices, while Potash EBITDA fell to $157M from $169M on a stronger shekel and higher energy and logistics costs. Full-year adjusted EBITDA guidance of $1.5-1.7B and potash volume guidance of 4.5-4.7 Mmt were reiterated, so the savings plan is the incremental item rather than a change to the outlook.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ICL was trading at $4.67 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6B. The 52-week trading range was $4.35 to $6.97. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.